Silencing The Dissenters: An Unwise, Ignominious Move

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) should reverse its directive stopping the work of researchers Walter Stewart and Ned Feder, reassigning them, and impounding their files. No public interest is served by silencing voices that speak out when something is amiss. The work of Stewart and Feder has focused on two areas. The first is the study of how the principles of science should guide the professional practices of scientists; the second is providing ad

Written byMargot O'toole
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) should reverse its directive stopping the work of researchers Walter Stewart and Ned Feder, reassigning them, and impounding their files. No public interest is served by silencing voices that speak out when something is amiss.

The work of Stewart and Feder has focused on two areas. The first is the study of how the principles of science should guide the professional practices of scientists; the second is providing advice and evaluation for scientists who believe they have witnessed scientific misconduct.

After having supported this work for years, NIDDK recently declared it to be outside its mission. However, that the study of the professional practices of scientists falls within the mission of the National Institutes of Health is shown by NIH's mandate requiring those institutions receiving NIH funds to offer courses on precisely these issues. In fact, of all the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies